A Partnership of the Crohn’s & Colitis Foundation and
the American Gastroenterological Association
the American Gastroenterological Association
Join the Conversation
The Crohn’s & Colitis Congress will provide Early Career Investigators Awards to up to ten abstract presenters for the 2025 meeting. Award recipients will receive complementary registration for the 2025 meeting.
Applicants for the award must:
Applications must be submitted online. Previous recipients of the award are not eligible to apply.
Award notifications will be emailed in mid-December.
Contact info@crohnscolitiscongress.org with any questions.
Kojo-Frimpong Awuah, Allegheny Health Network
RACIAL GAPS IN DIVERTICULITIS RECOVERY: THE ROLE OF INFLAMMATORY BOWEL DISEASE IN DISPARITY PATTERNS
Emily Shu-Yen Chan, Weiss Memorial Hospital
COMPARATIVE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS WITH VEDOLIZUMAB VS USTEKINUMAB IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASE: A PROPENSITY-MATCHED COHORT ANALYSIS
Marina Chulkina, Penn State Health Medical Center
FIBROBLAST MICROBIAL SENSING PLAYS A CRUCIAL ROLE IN MACROPHAGE-MEDIATED HOST DEFENSE AND PREDISPOSES TO IBD-RELEVANT COLITIS
Mahmut Demirturk, Emory University School of Medicine
IMMUNE MODULATION BY MACROPHAGE GALACTOSE C-TYPE LECTIN ALLEVIATE MURINE MODEL OF COLITIS
Jalpa Devi, Washington University in St. Louis
DEFINING RADIOLOGICAL HEALING IN PERIANAL FISTULISING CROHNS DISEASE A GLOBAL MODIFIED DELPHI CONSENSUS FROM THE TREATMENT OPTIMISATION AND CLASSIFICATION OF PERIANAL CROHNS DISEASE CONSORTIUM
Hailey DiCindio, Tufts University School of Medicine
RACIAL DISPARITIES ON ACCEPTANCE OF BIOLOGIC AND SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SURVEY STUDY
Jacques Gonzales, Michigan State University
NEURONAL PANNEXIN-1 SHAPES IMMUNE PROFILE AND INTESTINAL FUNCTIONS
William Massey, Cleveland Clinic Lerner Research Institute
MICROBIAL TRIMETHYLAMINE HOST TRACE AMINE ASSOCIATED RECEPTOR 5 (TAAR5) SIGNALING EXERTS PRO-FIBROTIC PROPERTIES IN IBD
Sidra Naz, MD Anderson Cancer Center
REGIONAL AND RACIAL DISPARITIES IN ULCERATIVE COLITIS AND CHOLANGIOCARCINOMA RELATED MORTALITY IN THE UNITED STATES AND TEXAS: A 21 YEAR OBSERVATIONAL STUDY
Ronaldo Paolo Panganiban, Penn State College of Medicine
TARGETING MYD88-JAK2 SIGNALING IN ABERRANTLY DIFFERENTIATED MESENCHYMAL PROGENITORS IN ULCERATIVE COLITIS
The Crohn’s & Colitis Congress will award complementary registration to the 2022 meeting to up to ten young investigators and five nurses and advanced practice providers. Applications will be accepted from 9 a.m. EDT on Wednesday, Sept. 8 through 9 p.m. EDT on Wednesday, Oct. 20, 2022.
Applicants are:
Recipients will receive complementary registration to the 2021 meeting.
The deadline for young investigators and nurses to submit an application for complementary registration to the 2022 meeting has passed.
Notifications will be sent to all applicants in early December.
Applicants for the Young Investigators Abstract Award must be:
Applications may be submitted at the abstract submission site. To apply for the award, complete the “Awards” fields when submitting an abstract. Applicants are asked to verify their eligibility and also provide a brief (4000 characters maximum) personal statement.
Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.
Applications are due at the abstract submission site by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.
Contact Congress administration with any questions about applying.
Nurses and advanced practice providers may apply for complementary registration to the 2022 Crohn’s & Colitis Congress.
As part of the application, applicants are asked to submit their CV and a brief (500 words or less) personal statement.
Applications must be submitted by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.
Contact Congress administration with any questions about applying.
